NKILT Therapeutics
PrivateLast Round
Accelerator
Sep 19, 2022
Company Overview
NKILT Therapeutics operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was an Accelerator round in September 2022.
NKILT Therapeutics is a biotechnology company developing allogeneic, off-the-shelf natural killer (NK) cell therapies for the treatment of leukemias and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NKILT Therapeutics Comparables
Compare NKILT Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shoreline Biosciences | 86% | |
| Invectys | 81% | |
| Indapta Therapeutics | 79% |
For institutional investors. Book with your work email.
NKILT Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NKILT Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Innovation Space | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 197% MoM, reaching 2K.
- May 2, 2025
Monthly visitors increased 73% MoM.
For institutional investors. Book with your work email.
NKILT Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NKILT Therapeutics's valuation, stock price, and market status.
Is NKILT Therapeutics a public or private company?
NKILT Therapeutics is a private company.
What is the current stock price of NKILT Therapeutics?
NKILT Therapeutics is a private company, so its shares have no public market price. Caplight tracks NKILT Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NKILT Therapeutics worth (valuation)?
Valuation information for NKILT Therapeutics is not publicly available.
Can I buy NKILT Therapeutics stock?
NKILT Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NKILT Therapeutics's last funding round?
NKILT Therapeutics's most recent funding round was Accelerator on September 19, 2022.
Who are the main investors in NKILT Therapeutics?
Key investors in NKILT Therapeutics include The Innovation Space.
Will NKILT Therapeutics IPO soon?
No public IPO plans have been announced for NKILT Therapeutics.
How can I track NKILT Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NKILT Therapeutics's shares on secondary markets.